AZD7442 – a potential combination therapy for the prevention and treatment of COVID-19

Trial Identifier: D8850C00001
Sponsor:AstraZeneca
Collaborator:
Parexel International
NCTID:NCT04507256
Start Date:August 2020
Primary Completion Date: October 2021
Study Completion Date: October 2021
Condition: COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

LanguageDescription
English version

Trial Locations

CountryLocation
United Kingdom Harrow, United Kingdom, HA1 3UJ